Compare MEDP & SNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEDP | SNA |
|---|---|---|
| Founded | 1992 | 1920 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1B | 18.3B |
| IPO Year | 2016 | N/A |
| Metric | MEDP | SNA |
|---|---|---|
| Price | $617.55 | $372.48 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $479.64 | $361.00 |
| AVG Volume (30 Days) | 200.5K | ★ 251.5K |
| Earning Date | 02-09-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | ★ 25.36 | N/A |
| EPS | 14.32 | ★ 19.06 |
| Revenue | $2,358,373,000.00 | ★ $5,115,400,000.00 |
| Revenue This Year | $21.43 | N/A |
| Revenue Next Year | $11.99 | $3.42 |
| P/E Ratio | $43.34 | ★ $19.50 |
| Revenue Growth | ★ 13.88 | 0.24 |
| 52 Week Low | $250.05 | $289.81 |
| 52 Week High | $628.92 | $372.63 |
| Indicator | MEDP | SNA |
|---|---|---|
| Relative Strength Index (RSI) | 61.09 | 69.82 |
| Support Level | $590.00 | $354.80 |
| Resistance Level | $624.00 | $365.65 |
| Average True Range (ATR) | 19.55 | 6.86 |
| MACD | 2.03 | 1.24 |
| Stochastic Oscillator | 83.08 | 94.36 |
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Snap-on is a manufacturer of premium tools, equipment, and diagnostics for professional technicians, primarily involved in the repair of passenger cars but having expanded into other industrial applications. The company's legacy business is selling hand tools through franchisee-operated mobile vans to technicians who purchase the tools at their own expense. The company also operates a commercial and industrial business that is focused on repair facilities serving other industries. The third segment, repair systems and information, targets auto OEMs and large dealerships more directly and also offers substantial diagnostic solutions to aid repairs. The company's finance arm provides financing to franchisees to run their operations, as well as underwriting end customer purchases.